Top-News
  • Depot
  • Watchlist
  • Glocke
  • Handeln

    • Inspira Technologies Oxy Ltd News

    1,89 $ -0,53% -0,01 $
    In : 1,7675 € | 26.04.24 22:00:00 Nasdaq aktualisieren | Orderbuch | Mehr Kurse »
    WKN: A3EZ7B
    ISIN: IL0011715781
    US-Symbol: IINN
    Typ: Aktie

    Inspira Technologies Oxy Ltd News

    25.04.24 - PR Newswire
    Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100
    Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100 PR Newswire
    16.04.24 - PR Newswire
    Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures
    Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures PR Newswire
    10.04.24 - PR Newswire
    Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections
    Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections PR Newswire
    03.04.24 - PR Newswire
    Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb
    Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb PR Newswire
    01.04.24 - PR Newswire
    Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager
    Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager PR Newswire
    25.03.24 - PR Newswire
    Inspira™ Technologies Reports Full Year 2023 Financial Results
    Inspira™ Technologies Reports Full Year 2023 Financial Results PR Newswire
    18.03.24 - PR Newswire
    Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets
    Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets PR Newswire
    12.03.24 - PR Newswire
    Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator
    Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator PR Newswire
    04.03.24 - PR Newswire
    Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
    Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days PR Newswire
    27.02.24 - PR Newswire
    Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
    Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone PR Newswire
    27.02.24 - PR Newswire
    Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements
    Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements PR Newswire
    22.02.24 - PR Newswire
    Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies
    Inspira™ introduces high-end platform for bio-​mimicking blood parameters for development and testing of core technologies PR Newswire
    14.02.24 - PR Newswire
    Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System
    Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System PR Newswire
    08.02.24 - PR Newswire
    Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device
    Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device PR Newswire
    30.01.24 - PR Newswire
    Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices
    Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices PR Newswire
    09.01.24 - PR Newswire
    Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity
    Inspira™ Announces Plans to Launch and Target Single-​Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity PR Newswire
    02.01.24 - PR Newswire
    Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device
    Inspira™ Technologies Signs Letter of Intent with Northwestern Memorial Hospital in Chicago for Clinical Use of INSPIRA™ ART100 Device PR Newswire
    28.12.23 - PR Newswire
    Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering
    Inspira™ Technologies Closes on $3.88 Million Registered Direct Offering PR Newswire
    27.12.23 - PR Newswire
    Thinking about buying stock in Senti Biosciences, Akebia Therapeutics, Nike, Inspira Technologies, or First Wave BioPharma?
    Thinking about buying stock in Senti Biosciences, Akebia Therapeutics, Nike, Inspira Technologies, or First Wave BioPharma? PR Newswire
    26.12.23 - PR Newswire
    Inspira Announces $3.88 Million Registered Direct Offering
    Inspira Announces $3.88 Million Registered Direct Offering PR Newswire

    Newssuche

    Videos

    26.04.24 +6,31%
    Technical Trading: Gold Long freitags
    Gold Long Typ: Turbo Open End WKN: NG8DB8 Hebel: 27 Laufzeit: OpenEnd Einstieg: Market ... Mehr »